bassiouny, Y. A., Y. A. Bayoumi, H. M. Gouda, and A. A. Hassan,
"Is intracytoplasmic sperm injection (ICSI) associated with higher incidence of congenital anomalies? A single center prospective controlled study in Egypt",
Journal of Maternal, Fetal and Neonatal Medicine, vol. 27, issue 3, pp. 279-282, 2014.
bassiouny, Y. A., D. M. Dakhly, Y. A. Bayoumi, and N. M. Hashish,
"Does the addition of growth hormone to the in vitro fertyilization/ intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial",
Fertility and Sterility, vol. 105, issue 3, pp. 697-702, 2016.
bassiouny, Y. A., W. A. Rabie, A. A. Hassan, and R. K. Darwish,
"Association of the luteinizing hormone/choriogonadotropin receptor gene polymorphism with polycystic ovary syndrome",
Gynecological Endocrinology, vol. 30, issue 6, pp. 428-430, 2014.
bassiouny, Y. A., D. M. R. Dakhly, Y. A. Bayoumi, N. M. Salah Eldin, H. M. Gouda, and A. A. Hassan,
"Randomized trial of combined cabergoline and coasting in preventing ovarian hyperstimlation syndrome during in vitro fertilization/intracytoplasmic sperm injection cycles",
International Journal of Gynecology and Obstetrics, vol. 140, issue 2, pp. 217-222, 2018.
Bayoumi, Y. A., D. M. R. Dakhly, Y. A. bassiouny, H. M. Gouda, M. A. Hassan, and A. A. Hassan,
"Post-placental intrauterine device insertion vs puerperal insertion in women undergoing caesarean delivery in Egypt: a 1 year randomised controlled trial",
European Journal of Contraception and Reproductive Health , vol. 25, issue 6, pp. 439-444, 2020.
Bayoumi, Y. A., Y. A. bassiouny, A. A. Hassan, H. M. Gouda, S. S. Zaki, and A. A. Abdelrazek,
"Is there a difference in the maternal and neonatal outcomes between patients discharged after 24 h versus 72 h following cesarean section? A prospective randomized observational study on 2998 patients",
Journal of Maternal Fetal and Neonatal Medicine, vol. 29, issue 8, pp. 1339-1343, 2016.
Bayoumi, Y. A., D. M. Dakhly, Y. A. bassiouny, and N. M. Hashish,
"Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response",
International Journal of Gynecology and Obstetrics, vol. 131, issue 3, pp. 305-308, 2015.
]